FBR Capital initiates coverage on Biota Pharmaceuticals (NASDAQ: BOTA) with a Outperform rating and a price target of $6.00, calling ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE